Christine Byrnes

Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS1
- SINCE2006

A Study to Evaluate RAF265 an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
April 2006 - December 2010
Melanoma
Raf265



